Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Ambea AB is a company operating within the healthcare and social services industry, primarily offering care services in the Nordic region. The company provides elderly care, disabled care, and psychosocial support services, focusing on high-quality living and well-being for its users. Founded in 1996, Ambea is headquartered in Stockholm, Sweden, and operates through several brands, including Vardaga and Nytida, ensuring a broad service coverage across Sweden, Norway, and Denmark. The company is strategically positioned through its strong regional presence and an extensive network of facilities and professionals, enabling efficient service delivery and high standards of care.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
Ambea ABEli Lilly
Last price
kr 184.90$1,417.54
Currency
SEK
USD
kr 15B$1.3T
19.3846.01
kr 9.54$30.81
0.670.45
kr 2.65$6.69
1.43%0.49%
Sector
HealthHealth
Employees
41,00050,000
Ticker
Skr AMBEA$LLY
Primary listing
XSTONYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in SkrAMBEA or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.